Chapter 01 Methodology And Scope
1.1 Market Segmentation & Scope
1.2 Segment Definitions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased Database
1.3.2 Internal Database
1.3.2.1 Secondary Sources
1.3.2.2 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Three Pillars Of Market Estimation
1.6.1.1 Secondary Market Research
1.6.1.2 Primary Market Intelligence
1.6.1.2.1. In-Depth Interviews (Idis)
1.6.1.2.2. Online Survey Program
1.6.2 Market Modeling & Forecasting
1.6.2.1 Procedure Volume Estimation (2021-2024)
1.6.2.2 Average Cost Estimation (2021-2024)
1.6.2.3 Forecasting (2025-2033)
1.6.2.4 Segment Share Analysis
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective - 1
1.9.2 Objective - 2
1.9.3 Objective - 3
Chapter 02 Executive Summary
2.1 Market Snapshot
2.2 Market Segmentation
2.3 Market Segmentation
2.4 Competitive Landscape
Chapter 03 Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Volume Of Cardiovascular And Radiological Procedures
3.2.1.1.1. Case Study: Peripheral Vascular Interventions For Peripheral Artery Disease (Pad) In Office-Based Labs
3.2.1.2 Growing Preference For Office-Based Labs Over Hospitals
3.2.1.2.1. Case Study: Trends In Peripheral Vascular Interventions And The Rise Of Office-Based Laboratories In The U.S.
3.2.1.2.2. Case Study: Utilization Patterns And Outcomes Of Pad Procedures In Office-Based Labs Versus Hospitals.
3.2.1.3 Advancing Technology And Rising Preference For Minimally Invasive Procedures
3.2.2 Market Restraint Analysis
3.2.2.1 High Risk Option For Severe Cases
3.2.2.2 High Capital Investment And Operational Costs
3.2.3 Market Opportunity Analysis
3.2.3.1 Strategic Partnerships And Physician Ownership
3.2.4 Market Challenges Analysis
3.2.4.1 Competitive Pressure From Ambulatory Surgical Centers (Ascs) And Hospital Outpatient Departments (Hopds)
3.3 Regulatory Framework & Reimbursement Scenario
3.3.1 Regulatory Framework
3.3.2 Reimbursement Scenario
3.4 Business Environment Analysis Tools
3.4.1 Porter’s Five Forces Analysis
3.4.2 Pestle Analysis
Chapter 04 U.S. Office-Based Labs Market: Modality Estimates & Trend Analysis
4.1 U.S. Office-Based Labs Market: Modality Movement Share Analysis, 2024 & 2033
4.2 U.S. Office-Based Labs Market: Modality Segment Dashboard
4.3 U.S. Office-Based Labs Market Size & Forecast And Forecasts, By Modality (Usd Billion)
4.3.1 Single Specialty Labs
4.3.1.1 Single Specialty Labs Market, 2021 - 2033 (Usd Billion)
4.3.2 Multi-Specialty Labs
4.3.2.1 Multi-Specialty Labs Market, 2021 - 2033 (Usd Billion)
4.3.3 Hybrid Labs
4.3.3.1 Hybrid Labs Market, 2021 - 2033 (Usd Billion)
Chapter 05 U.S. Office-Based Labs Market: Service Estimates & Trend Analysis
5.1 U.S. Office-Based Labs Market: Service Movement Share Analysis, 2024 & 2033
5.2 U.S. Office-Based Labs Market: Service Segment Dashboard
5.3 U.S. Office-Based Labs Market Size & Forecast And Forecasts, By Service (Usd Billion)
5.3.1 Peripheral Vascular Intervention
5.3.1.1 Reimbursement Scenario
5.3.1.2 Peripheral Vascular Intervention Market, 2021 - 2033 (Usd Billion)
5.3.1.3 Peripheral Vascular Intervention Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.1.4 Atherectomy
5.3.1.4.1 Atherectomy Market, 2021 - 2033 (Usd Billion)
5.3.1.4.2 Atherectomy Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.1.5 Vascular Angioplasty
5.3.1.5.1 Vascular Angioplasty Market, 2021 - 2033 (Usd Billion)
5.3.1.5.2 Vascular Angioplasty Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.1.6 Stenting
5.3.1.6.1 Stenting Market, 2021 - 2033 (Usd Billion)
5.3.1.6.2 Stenting Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.1.7 Other Pvi
5.3.1.7.1 Other Pvi Market, 2021 - 2033 (Usd Billion)
5.3.1.7.2 Other Pvi Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.2 Cardiac
5.3.2.1 Reimbursement Scenario
5.3.2.2 Cardiac Market, 2021 - 2033 (Usd Billion)
5.3.2.3 Cardiac Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3 Interventional Radiology
5.3.3.1 Reimbursement Scenario
5.3.3.2 Interventional Radiology Market, 2021 - 2033 (Usd Billion)
5.3.3.3 Interventional Radiology Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3.4 Uterine Fibroid Embolization (Ufe)
5.3.3.4.1 Uterine Fibroid Embolization (Ufe) Market, 2021 - 2033 (Usd Billion)
5.3.3.4.2 Uterine Fibroid Embolization (Ufe) Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3.5 Prostate Artery Embolization (Pae)
5.3.3.5.1 Prostate Artery Embolization (Pae) Market, 2021 - 2033 (Usd Billion)
5.3.3.5.2 Prostate Artery Embolization (Pae) Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3.6 Y90/Oncology
5.3.3.6.1 Y90/Oncology Market, 2021 - 2033 (Usd Billion)
5.3.3.6.2 Y90/Oncology Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3.7 Other Ir
5.3.3.7.1 Other Ir Market, 2021 - 2033 (Usd Billion)
5.3.3.7.2 Other Ir Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.4 Venous
5.3.4.1 Reimbursement Scenario
5.3.4.2 Venous Market, 2021 - 2033 (Usd Million)
5.3.4.3 Venous Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3.4 Rfa (Radiofrequency Ablation) And Evlt (Endovenous Laser Therapy)
5.3.3.4.1 Rfa (Radiofrequency Ablation) And Evlt (Endovenous Laser Therapy) Market, 2021 - 2033 (Usd Billion)
5.3.3.4.2 Urfa (Radiofrequency Ablation) And Evlt (Endovenous Laser Therapy) Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3.5 Sclerotherapy/Glue
5.3.3.5.1 Sclerotherapy/Glue Market, 2021 - 2033 (Usd Billion)
5.3.3.5.2 Sclerotherapy/Glue Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3.6 Venous Stenting
5.3.3.6.1 Venous Stenting Market, 2021 - 2033 (Usd Billion)
5.3.3.6.2 Venous Stenting Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.3.7 Other Deep Vein
5.3.3.7.1 Other Deep Vein Market, 2021 - 2033 (Usd Billion)
5.3.3.7.2 Other Deep Vein Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.5 Endovascular Interventions
5.3.5.1 Reimbursement Scenario
5.3.5.2 Endovascular Interventions Market, 2021 - 2033 (Usd Million)
5.3.5.3 Endovascular Interventions Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
5.3.6 Others
5.3.6.1 Reimbursement Scenario
5.3.6.2 Other Services Market, 2021 - 2033 (Usd Million)
5.3.6.3 Other Services Procedure Volume Estimates & Forecasts, 2021 - 2033 (Units)
Chapter 06 U.S. Office-Based Labs Market: Specialist Estimates & Trend Analysis
6.1 U.S. Office-Based Labs Market: Specialist Movement Share Analysis, 2024 & 2033
6.2 U.S. Office-Based Labs Market: Specialist Segment Dashboard
6.3 U.S. Office-Based Labs Market Size & Forecast And Forecasts, By Specialist (Usd Billion)
6.3.1 Vascular Surgeons
6.3.1.1 Vascular Surgeons Market, 2021 - 2033 (Usd Billion)
6.3.2 Interventional Cardiologists
6.3.2.1 Interventional Cardiologists Market, 2021 - 2033 (Usd Billion)
6.3.3 Interventional Radiologists
6.3.3.1 Interventional Radiologists Market, 2021 - 2033 (Usd Billion)
6.3.4 Other Specialists
6.3.4.1 Other Specialists Market, 2021 - 2033 (Usd Billion)
Chapter 07 U.S. Office-Based Labs Market: Competitive Landscape
7.1 Suppliers’ Competition Categorization
7.2 Service Providers’ Competition Categorization
7.2.1 Company Market Position Analysis: Suppliers
7.2.2 Company Market Position Analysis: Service Provider
7.3 Strategy Mapping
7.3.1 New Launch And Approval
7.3.2 Acquisition
7.3.3 Partnership & Collaboration
7.3.4 Others
7.4 Company Profiles
7.3.1 Koninklijke Philips N.V.
7.3.1.1 Company Overview
7.3.1.2 Financial Performance
7.3.1.3 Product/Service Benchmarking
7.3.1.4 Strategic Initiatives
7.3.2 Ge Healthcare
7.3.2.1 Company Overview
7.3.2.2 Financial Performance
7.3.2.3 Product/Service Benchmarking
7.3.2.4 Strategic Initiatives
7.3.3 Siemens Healthineers Ag
7.3.3.1 Company Overview
7.3.3.2 Financial Performance
7.3.3.3 Product/Service Benchmarking
7.3.3.4 Strategic Initiatives
7.3.4 Medtronic Plc
7.3.4.1 Company Overview
7.3.4.2 Financial Performance
7.3.4.3 Product/Service Benchmarking
7.3.4.4 Strategic Initiatives
7.3.5 Boston Scientific Corporation
7.3.5.1 Company Overview
7.3.5.2 Financial Performance
7.3.5.3 Product/Service Benchmarking
7.3.5.4 Strategic Initiatives
7.3.6 Abbott
7.3.6.1 Company Overview
7.3.6.2 Financial Performance
7.3.6.3 Product/Service Benchmarking
7.3.6.4 Strategic Initiatives
7.3.7 Envision Healthcare Corporation (Kkr)
7.3.7.1 Company Overview
7.3.7.2 Financial Performance
7.3.7.3 Product/Service Benchmarking
7.3.7.4 Strategic Initiatives
7.3.8 Surgical Care Affiliates (Sca)
7.3.8.1 Company Overview
7.3.8.2 Financial Performance
7.3.8.3 Product/Service Benchmarking
7.3.8.4 Strategic Initiatives
7.3.9 Surgery Partners
7.3.9.1 Company Overview
7.3.9.2 Financial Performance
7.3.9.3 Product/Service Benchmarking
7.3.9.4 Strategic Initiatives
7.3.10 Cardiovascular Coalition
7.3.10.1 Company Overview
7.3.10.2 Financial Performance
7.3.10.3 Product/Service Benchmarking
7.3.10.4 Strategic Initiatives
7.3.11 Th Medical
7.3.11.1 Company Overview
7.3.11.2 Financial Performance
7.3.11.3 Product/Service Benchmarking
7.3.11.4 Strategic Initiatives
7.3.12 Vascular Care Group
7.3.12.1 Company Overview
7.3.12.2 Financial Performance
7.3.12.3 Product/Service Benchmarking
7.3.12.4 Strategic Initiatives
7.3.13 Coastal Vascular Institute
7.3.13.1 Company Overview
7.3.13.2 Financial Performance
7.3.13.3 Product/Service Benchmarking
7.3.14.4 Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Type of procedures performed in OBLs
Table 4 Catheter Placement(s): Medicare base case coding scenarios
Table 5 Arterial Shunting Coil Embolization (if required): Medicare base case coding scenarios
Table 6 Hepatic Angiogram: Medicare base case coding scenarios
Table 7 Volume Imaging Options: Medicare base case coding scenarios
Table 8 CT Acquisition (maybe billed in conjunction with CPT 76377): Medicare base case coding scenarios
Table 9 Mapping Options: Medicare base case coding scenarios
Table 10 Codes applicable between mapping and treatment: Medicare base case coding scenarios
Table 11 Catheter Placement (Phase II): Medicare base case coding scenarios
Table 12 Hepatic Angiogram (Phase II): Medicare base case coding scenarios
Table 13 Tumor Embolization Phase II: Medicare base case coding scenarios
Table 14 Microspheres Administration: Authorized User Codes (AU)
Table 15 Post Treatment Imaging (Provider Preference): Medicare base case coding scenarios
Table 16 U.S. office-based labs market revenue estimates and forecast, by Modality, 2021 - 2033 (USD billion)
Table 17 U.S. office-based labs market revenue estimates and forecast, by Service, 2021 - 2033 (USD billion)
Table 18 U.S. office-based labs market revenue estimates and forecast, by Service, 2021 - 2033 (Number of Procedures)
Table 19 U.S. Peripheral Vascular Intervention (PVI) in OBLs market revenue estimates and forecast, by Service, 2021 - 2033 (USD Million)
Table 20 U.S. Peripheral Vascular Intervention (PVI) in OBLs market revenue estimates and forecast, by Service Type, 2021 - 2033 (Number of Procedures)
Table 21 U.S. venous procedures in OBLs market revenue estimates and forecast, by service type, 2021 - 2033 (USD Million)
Table 22 U.S. venous procedures in OBLs market revenue estimates and forecast, by service type, 2021 - 2033 (Number of Procedures)
Table 23 U.S. interventional radiology in OBLs market revenue estimates and forecast, by service type, 2021 - 2033 (USD Million)
Table 24 U.S. interventional radiology in OBLs market revenue estimates and forecast, by service type, 2021 - 2033 (Number of Procedures)
Table 25 U.S. office-based labs market revenue estimates and forecast, by Specialist, 2021 - 2033 (USD billion)
Table 26 Shortage of vascular surgeons by workload analysis
List of Figures
Fig. 1 U.S. office-based labs segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Research methodology framework
Fig. 10 Secondary research framework
Fig. 11 Secondary research framework
Fig. 12 Market snapshot
Fig. 13 Market segmentation
Fig. 14 Market segmentation
Fig. 15 Competitive landscape
Fig. 16 U.S. office-based labs market dynamics
Fig. 17 U.S. office-based labs market: Porter’s five forces analysis
Fig. 18 U.S. office-based labs market: PESTLE analysis
Fig. 19 U.S. office-based labs market: Modality movement share analysis
Fig. 20 U.S. office-based labs market: Modality segment dashboard
Fig. 21 Single specialty labs market, 2021 - 2033 (USD Billion)
Fig. 22 Multi-specialty labs market, 2021 - 2033 (USD Billion)
Fig. 23 Hybrid market, 2021 - 2033 (USD Billion)
Fig. 24 U.S. office-based labs market: Service movement share analysis
Fig. 25 U.S. office-based labs market: Service segment dashboard
Fig. 26 Peripheral vascular intervention market, 2021 - 2033 (USD Billion)
Fig. 27 Peripheral vascular intervention procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 28 Atherectomy market, 2021 - 2033 (USD Billion)
Fig. 29 Atherectomy procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 30 Vascular angioplasty market, 2021 - 2033 (USD Billion)
Fig. 31 Vascular angioplasty procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 32 Stenting market, 2021 - 2033 (USD Billion)
Fig. 33 Stenting procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 34 Other PVI market, 2021 - 2033 (USD Billion)
Fig. 35 Other PVI procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 36 Cardiac market, 2021 - 2033 (USD Billion)
Fig. 37 Cardiac procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 38 Interventional radiology market, 2021 - 2033 (USD Billion)
Fig. 39 Interventional radiology procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 40 Uterine Fibroid Embolization (UFE) market, 2021 - 2033 (USD Billion)
Fig. 41 Uterine Fibroid Embolization (UFE) procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 42 Prostate Artery Embolization (PAE) market, 2021 - 2033 (USD Billion)
Fig. 43 Prostate Artery Embolization (PAE) procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 44 Y90/Oncology market, 2021 - 2033 (USD Billion)
Fig. 45 Y90/Oncology procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 46 Other IR market, 2021 - 2033 (USD Billion)
Fig. 47 Other IR procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 48 Venous market, 2021 - 2033 (USD Million)
Fig. 49 Venous procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 50 RFA (Radiofrequency Ablation) and EVLT (Endovenous Laser Therapy) market, 2021 - 2033 (USD Million)
Fig. 51 RFA (Radiofrequency Ablation) and EVLT (Endovenous Laser Therapy) procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 52 Sclerotherapy/Glue market, 2021 - 2033 (USD Million)
Fig. 53 Sclerotherapy/Glue procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 54 Venous stenting market, 2021 - 2033 (USD Million)
Fig. 55 Venous stenting procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 56 Other deep vein market, 2021 - 2033 (USD Million)
Fig. 57 Other deep vein procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 58 Endovascular interventions market, 2021 - 2033 (USD Million)
Fig. 59 Endovascular interventions procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 60 Other services market, 2021 - 2033 (USD Million)
Fig. 61 Other services procedure volume estimates & forecasts, 2021 - 2033 (Units)
Fig. 62 U.S. office-based labs market: Specialist movement share analysis
Fig. 63 U.S. office-based labs market: Specialist segment dashboard
Fig. 64 Vascular surgeons market, 2021 - 2033 (USD Billion)
Fig. 65 Interventional cardiologists market, 2021 - 2033 (USD Billion)
Fig. 66 Interventional radiologists market, 2021 - 2033 (USD Billion)
Fig. 67 Other specialists market, 2021 - 2033 (USD Billion)
Fig. 68 Suppliers’ competition categorization
Fig. 69 Service providers’ competition categorization
Fig. 70 Company market position analysis: Suppliers
Fig. 71 Company market position analysis: Service providers
Fig. 72 Strategy mapping
